CIK 0000899923 · Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870494517
- Phone
- 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-09 | Riggsbee Richard Bryan Chief Financial Officer | Shares withheld for taxes | −7,419 | $30.88 | $229K | 356,765 |
| 2021-10-09 | Hart Jayne B. Chief People Officer | Shares withheld for taxes | −1,978 | $30.88 | $61K | 149,163 |
| 2021-10-09 | Hart Jayne B. Chief People Officer | Shares withheld for taxes | −2,948 | $30.88 | $91K | 146,215 |
| 2021-10-09 | Verratti Mark President, Myriad Neuroscience | Shares withheld for taxes | −3,349 | $30.88 | $103K | 199,010 |
| 2021-10-09 | Verratti Mark President, Myriad Neuroscience | Shares withheld for taxes | −4,991 | $30.88 | $154K | 194,019 |
| 2021-10-09 | LANCHBURY JERRY S Chief Scientific Officer | Shares withheld for taxes | −4,341 | $30.88 | $134K | 270,794 |
| 2021-10-09 | LANCHBURY JERRY S Chief Scientific Officer | Shares withheld for taxes | −6,470 | $30.88 | $200K | 264,324 |
| 2021-10-01 | Lambert Nicole See Remarks | Sale | −1,420 | $31.57 | $45K | 176,652 |
| 2021-09-27 | Lambert Nicole See Remarks | Sale | −10,112 | $33.10 | $335K | 178,072 |
| 2021-09-26 | Haas Kevin Richard Chief Technology Officer | Shares withheld for taxes | −865 | $33.31 | $29K | 54,902 |
| 2021-09-26 | Lambert Nicole See Remarks | Shares withheld for taxes | −3,426 | $33.31 | $114K | 188,184 |
| 2021-09-26 | Riggsbee Richard Bryan Chief Financial Officer | Shares withheld for taxes | −4,541 | $33.31 | $151K | 369,163 |
| 2021-09-26 | Hart Jayne B. Chief People Officer | Shares withheld for taxes | −2,216 | $33.31 | $74K | 110,120 |
| 2021-09-26 | Verratti Mark President, Myriad Neuroscience | Shares withheld for taxes | −3,514 | $33.31 | $117K | 202,359 |
| 2021-09-25 | Haas Kevin Richard Chief Technology Officer | Shares withheld for taxes | −346 | $33.31 | $12K | 55,767 |
| 2021-09-25 | Lambert Nicole See Remarks | Shares withheld for taxes | −1,311 | $33.31 | $44K | 191,610 |
| 2021-09-25 | Riggsbee Richard Bryan Chief Financial Officer | Shares withheld for taxes | −11,907 | $33.31 | $397K | 373,704 |
| 2021-09-25 | Hart Jayne B. Chief People Officer | Shares withheld for taxes | −3,878 | $33.31 | $129K | 112,336 |
| 2021-09-25 | Verratti Mark President, Myriad Neuroscience | Shares withheld for taxes | −6,746 | $33.31 | $225K | 205,873 |
Page 21 of 21 · 419 trades